From the Guidelines
The Omnipod 5 Automated Insulin Delivery System does have an exercise mode, which allows users to temporarily adjust their target glucose level during periods of physical activity. This feature is crucial in reducing the risk of exercise-induced hypoglycemia, as physical activity increases insulin sensitivity and glucose utilization by muscles, leading to potential blood sugar drops 1.
Key Features of the Exercise Mode
- The exercise mode, also known as the "Activity" feature, raises the target glucose level to prespecified levels, often accompanied by more conservative insulin delivery 1
- This feature can be programmed in various time increments and is available in most AID systems currently on the market, including the Omnipod 5 1
- The Activity feature helps minimize hypoglycemia and hyperglycemia by adjusting insulin doses based on predicted glucose levels and user-inputted activity duration 1
Recommendations for Use
- Users should activate the Activity feature before starting exercise, ideally 1-2 hours prior, to allow the system to adjust insulin delivery appropriately [based on general clinical guidelines and (1)]
- The feature can be activated through the Omnipod 5 Controller or compatible smartphone app, making it convenient for users to manage their insulin delivery during physical activity [based on general knowledge of the Omnipod 5 system and (1)]
- By utilizing the Activity feature, users can reduce the risk of exercise-induced hypoglycemia and maintain better glucose control during and after physical activity 1
From the Research
Omnipod 5 Features
- The provided studies do not mention the Omnipod 5 or its features, including an activity or exercise mode 2, 3, 4, 5, 6.
Hypoglycemia Research
- The studies focus on hypoglycemia in diabetes, its pathophysiology, treatment, and prevention 2, 3, 4, 5, 6.
- They discuss the importance of patient education and personalized goals for glycemic control to prevent hypoglycemia 3.
- The research also explores the consequences of hypoglycemia, including acute and cumulative effects on insulin-treated diabetes 4.